Partnering in Technologies

Our experience

Scientists at our major research sites, together with our academic and industry partners, are pursuing novel technologies to support therapeutic advances in areas of key unmet medical need. We have the ambition to identify and translate the most promising technology innovations into impactful applications across a broad range of research fields.

Our Technology partnering interests

Our partnering interests offer various opportunities for collaboration:

• Technologies that help to accelerate small molecule drug discovery and development
• Hit/Tool/Lead generation technologies: Rapid generation of compounds for the validation and progression of new therapeutic concepts (NTCs)
• Advanced computational biology methods and analytics to identify and evaluate NTCs
• New approaches to access hard-to-drug targets
• New modalities beyond small molecules to address difficult targets and expand our target space
• (Targeted) Intracellular delivery technologies
• Long-acting injectables and depot technologies for sustained drug release

Our Biotherapeutic Technology partnering interests

Our partnering interests offer various opportunities for collaboration:

• In-silico and AI discovery and optimization platforms for biotherapeutics
• Biologic enabling technologies and formats supporting therapeutic areas (Cardiovascular-Renal-Metabolic diseases, Immunology and Inflammation, Mental Health disorders and Neuroscience, Oncology, Respiratory diseases and Retinal Health)
• Technologies to enable function-driven first-in-class antibody identification
• New technologies for half-life extension systemically and in the eye
• Accelerating timelines from tool to lead, lead to drug, as well, as in drug development